APTEVO THERAPEUTICS INC (APVO)
US03835L3069 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -17.41M | 8.03M | -28.46M | -17.75M | -40.45M | |||
| Depreciation Amortization | 567.00K | 900.00K | 1.14M | 1.41M | 2.24M | |||
| Income Taxes - Deferred | N/A | N/A | N/A | N/A | N/A | |||
| Change In Working Capital | 2.91M | 2.14M | -2.66M | -2.41M | -2.22M | |||
| Interest Paid | N/A | N/A | N/A | N/A | N/A | |||
| Taxes Paid | N/A | N/A | N/A | N/A | N/A | |||
| Other non cash items | 2.20M | -32.09M | 8.29M | -10.57M | -1.95M | |||
| OPERATING CASH FLOW | -11.73M | -21.02M | -21.68M | -29.32M | -42.38M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | 0.00 | -30.00K | -710.00K | -90.00K | -150.00K | |||
| Other Investing Activity | N/A | N/A | 0.00 | 28.12M | 4.25M | |||
| INVESTING CASH FLOW | 0.00 | -30.00K | -710.00K | 28.03M | 4.10M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -3.47M | -12.27M | -10.55M | 2.63M | -140.00K | |||
| Stock Issued/Repurchased | 9.47M | 6.93M | 11.44M | 21.26M | 20.34M | |||
| Other Financing Activity | -10.00K | 2.72M | 25.27M | -10.00K | -60.00K | |||
| FINANCING CASH FLOW | 6.00M | -2.62M | 26.16M | 23.87M | 20.15M | |||
| CHANGE IN CASH | -5.73M | -23.67M | 3.77M | 22.58M | -18.13M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -11.73M | -21.02M | -21.68M | -29.32M | -42.38M | |||
| Capital Expenditure | 0.00 | -30.00K | -710.00K | -90.00K | -150.00K | |||
| FREE CASH FLOW | -11.73M | -21.05M | -22.39M | -29.41M | -42.53M | |||
All data in USD